Audit in process? Call the number on your audit letter to get options.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
August 18, 2021 - The FDA approved Mayne Pharma’s Lexette (halobetasol propionate), for the topical treatment of plaque psoriasis in patients 12 years of age and older.
Download PDF
Return to publications
